- Home
- KZIA vs BNZI Comparison
KZIA vs BNZI Comparison
Compare KZIA & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- BNZI
- Stock Information
- Founded
- KZIA 1994
- BNZI 2016
- Country
- KZIA Australia
- BNZI United States
- Employees
- KZIA N/A
- BNZI N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- KZIA Health Care
- BNZI
- Exchange
- KZIA Nasdaq
- BNZI Nasdaq
- Market Cap
- KZIA 5.1M
- BNZI 11.5M
- IPO Year
- KZIA 1999
- BNZI N/A
- Fundamental
- Price
- KZIA $10.45
- BNZI $4.16
- Analyst Decision
- KZIA Strong Buy
- BNZI Strong Buy
- Analyst Count
- KZIA 2
- BNZI 1
- Target Price
- KZIA $14.00
- BNZI $24.00
- AVG Volume (30 Days)
- KZIA 745.7K
- BNZI 481.0K
- Earning Date
- KZIA 07-22-2025
- BNZI 08-13-2025
- Dividend Yield
- KZIA N/A
- BNZI N/A
- EPS Growth
- KZIA N/A
- BNZI N/A
- EPS
- KZIA N/A
- BNZI N/A
- Revenue
- KZIA $1,549,158.00
- BNZI $6,827,490.00
- Revenue This Year
- KZIA N/A
- BNZI $337.60
- Revenue Next Year
- KZIA N/A
- BNZI $91.81
- P/E Ratio
- KZIA N/A
- BNZI N/A
- Revenue Growth
- KZIA 248983.08
- BNZI 52.95
- 52 Week Low
- KZIA $2.86
- BNZI $3.93
- 52 Week High
- KZIA $79.00
- BNZI $112.00
- Technical
- Relative Strength Index (RSI)
- KZIA 72.75
- BNZI 24.16
- Support Level
- KZIA $5.86
- BNZI $4.11
- Resistance Level
- KZIA $7.20
- BNZI $6.90
- Average True Range (ATR)
- KZIA 1.17
- BNZI 0.69
- MACD
- KZIA 0.15
- BNZI -0.10
- Stochastic Oscillator
- KZIA 82.21
- BNZI 4.03
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.